Targeting LRRK2 mRNA stability in Parkinson's disease.

Abstract excerpt

In a recent study, Liu and colleagues demonstrated a role for the purine biosynthesis enzyme ATIC and its substrate in regulating the protein levels of the Parkinson's disease kinase LRRK2, which rescues neurodegeneration and neuroinflammation in distinct animal models. This work highlights a novel avenue to target LRRK2 protein levels as a strategy to prevent neurodegeneration in Parkinson's disease.

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Leucine-Rich Repeat Serine-Threonine Protein Kinase-2
• Share to Models, Animal
• Share to Mutation